I

InfuSystem Holdings Inc
AMEX:INFU

Watchlist Manager
InfuSystem Holdings Inc
AMEX:INFU
Watchlist
Price: 8.86 USD -1.01% Market Closed
Market Cap: 188.1m USD
Have any thoughts about
InfuSystem Holdings Inc?
Write Note

InfuSystem Holdings Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InfuSystem Holdings Inc
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
I
InfuSystem Holdings Inc
AMEX:INFU
Gross Profit
$67.1m
CAGR 3-Years
4%
CAGR 5-Years
9%
CAGR 10-Years
3%
DaVita Inc
NYSE:DVA
Gross Profit
$4.2B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
1%
Quest Diagnostics Inc
NYSE:DGX
Gross Profit
$3.1B
CAGR 3-Years
-11%
CAGR 5-Years
3%
CAGR 10-Years
1%
CVS Health Corp
NYSE:CVS
Gross Profit
$52.4B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
8%
Cigna Corp
NYSE:CI
Gross Profit
$26.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Gross Profit
$3.5B
CAGR 3-Years
-17%
CAGR 5-Years
2%
CAGR 10-Years
5%
No Stocks Found

InfuSystem Holdings Inc
Glance View

Market Cap
188.1m USD
Industry
Health Care

InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 420 full-time employees. The company went IPO on 2006-06-15. The Company’s segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Company’s core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.

INFU Intrinsic Value
10.8 USD
Undervaluation 18%
Intrinsic Value
Price
I

See Also

What is InfuSystem Holdings Inc's Gross Profit?
Gross Profit
67.1m USD

Based on the financial report for Sep 30, 2024, InfuSystem Holdings Inc's Gross Profit amounts to 67.1m USD.

What is InfuSystem Holdings Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
3%

Over the last year, the Gross Profit growth was 4%. The average annual Gross Profit growth rates for InfuSystem Holdings Inc have been 4% over the past three years , 9% over the past five years , and 3% over the past ten years .

Back to Top